101.51
price down icon0.91%   -0.924
 
loading
Boston Scientific Corp stock is traded at $101.51, with a volume of 2.44M. It is down -0.91% in the last 24 hours and up +3.38% over the past month. Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$102.43
Open:
$102.31
24h Volume:
2.44M
Relative Volume:
0.29
Market Cap:
$150.40B
Revenue:
$19.35B
Net Income/Loss:
$2.78B
P/E Ratio:
54.29
EPS:
1.8696
Net Cash Flow:
$3.49B
1W Performance:
+1.60%
1M Performance:
+3.38%
6M Performance:
-0.67%
1Y Performance:
+19.75%
1-Day Range:
Value
$101.20
$102.86
1-Week Range:
Value
$100.55
$105.49
52-Week Range:
Value
$80.64
$109.50

Boston Scientific Corp Stock (BSX) Company Profile

Name
Name
Boston Scientific Corp
Name
Phone
508-683-4000
Name
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Name
Employee
53,000
Name
Twitter
@bostonsci
Name
Next Earnings Date
2025-10-22
Name
Latest SEC Filings
Name
BSX's Discussions on Twitter

Compare BSX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
BSX
Boston Scientific Corp
101.50 151.78B 19.35B 2.78B 3.49B 1.8696
Medical Devices icon
ABT
Abbott Laboratories
127.25 221.35B 43.84B 13.94B 6.78B 7.9979
Medical Devices icon
SYK
Stryker Corp
378.69 146.70B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
93.95 120.73B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
82.12 47.45B 5.69B 1.41B 577.90M 6.9828

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-03-25 Downgrade Erste Group Buy → Hold
Sep-08-25 Upgrade Oppenheimer Perform → Outperform
Jun-16-25 Initiated Leerink Partners Outperform
Apr-16-25 Upgrade Needham Hold → Buy
Jan-10-25 Upgrade Deutsche Bank Hold → Buy
Oct-18-24 Downgrade Needham Buy → Hold
May-30-24 Initiated Goldman Buy
Feb-01-24 Upgrade Mizuho Neutral → Buy
Jul-19-23 Initiated Robert W. Baird Outperform
Jun-30-23 Initiated CL King Buy
May-30-23 Resumed Morgan Stanley Overweight
Mar-29-23 Initiated UBS Buy
Dec-22-22 Initiated Mizuho Neutral
Dec-20-22 Resumed Citigroup Buy
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Buy
Jul-06-22 Initiated Wolfe Research Outperform
May-27-22 Upgrade Needham Hold → Buy
Apr-13-22 Resumed Truist Buy
Mar-02-22 Resumed BofA Securities Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
May-26-21 Downgrade Needham Buy → Hold
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Overweight
Sep-17-20 Initiated Truist Buy
Sep-11-20 Initiated Wolfe Research Peer Perform
Apr-22-20 Downgrade SVB Leerink Outperform → Mkt Perform
Apr-01-20 Upgrade Goldman Neutral → Buy
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Buy
Dec-30-19 Reiterated Cowen Outperform
Dec-19-19 Downgrade Needham Strong Buy → Buy
Sep-05-19 Resumed JP Morgan Overweight
Sep-03-19 Resumed Barclays Overweight
May-13-19 Upgrade Evercore ISI In-line → Outperform
Nov-28-18 Initiated UBS Buy
Oct-16-18 Initiated Barclays Overweight
Oct-02-18 Reiterated Morgan Stanley Overweight
Sep-07-18 Reiterated Needham Strong Buy
Sep-04-18 Upgrade Jefferies Hold → Buy
Jul-06-18 Reiterated Needham Strong Buy
Jun-27-18 Initiated Bernstein Outperform
Apr-26-18 Reiterated Needham Strong Buy
View All

Boston Scientific Corp Stock (BSX) Latest News

pulisher
07:30 AM

Can Boston Scientific Corporation stock sustain revenue momentumLayoff News & Verified Momentum Stock Alerts - newser.com

07:30 AM
pulisher
04:36 AM

Risk vs reward if holding onto Boston Scientific Corporation2025 Support & Resistance & Reliable Breakout Forecasts - newser.com

04:36 AM
pulisher
12:29 PM

Will Boston Scientific Corporation stock gain from strong economyAnalyst Downgrade & Low Risk Profit Maximizing Plans - newser.com

12:29 PM
pulisher
Oct 27, 2025

How Boston Scientific Corporation stock moves in volatile trading sessions2025 Stock Rankings & Expert Approved Momentum Ideas - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is Boston Scientific Corporation stock ready for a breakoutShort Setup & Daily Technical Forecast Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What market sentiment indicators show for Boston Scientific Corporation stockDip Buying & Long-Term Safe Return Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Boston Scientific’s Innovative Approach to Gastric Outlet Obstruction: Study Update - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Boston Scientific’s SIMPLAAFY Trial: A New Frontier in Atrial Fibrillation Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Boston Scientific’s Orbera365™ Study: A New Frontier in Weight Loss Management - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Boston Scientific’s RHAPSODY Study: A Step Forward in Cardiac Care Innovation - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Boston Scientific’s Hot AXIOS™ Stent Study: A Potential Game-Changer in Bile Duct Drainage - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Boston Scientific’s Innovative Approach to Atrial Fibrillation: A Study Update - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Boston Scientific’s Vercise™ DBS Study: A Real-World Evaluation of Dystonia Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Chart based analysis of Boston Scientific Corporation trends2025 Dividend Review & Stepwise Trade Execution Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Boston Scientific shares positive Agent drug-coated balloon findings - MassDevice

Oct 27, 2025
pulisher
Oct 27, 2025

Does Boston Scientific (BSX) Have the Potential to Rally 25.61% as Wall Street Analysts Expect? - Yahoo Finance

Oct 27, 2025
pulisher
Oct 27, 2025

Is Boston Scientific Corporation stock a buy in volatile marketsWeekly Trend Recap & Accurate Technical Buy Alerts - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Boston Scientific Hits Day High with 3.95% Surge, Outperforming S&P 500 - Markets Mojo

Oct 26, 2025
pulisher
Oct 26, 2025

Comparing Boston Scientific Corporation in custom built stock radarsMarket Growth Summary & Real-Time Chart Breakout Alerts - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

Evaluating Boston Scientific Corporation with trendline analysisJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com

Oct 25, 2025
pulisher
Oct 24, 2025

Boston Scientific Corporation (BSX) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade

Oct 24, 2025
pulisher
Oct 24, 2025

Truist Financial Remains a Buy on Boston Scientific (BSX) - The Globe and Mail

Oct 24, 2025
pulisher
Oct 24, 2025

Fund Update: PARNASSUS INVESTMENTS, LLC added 6,868,459 shares of BOSTON SCIENTIFIC (BSX) to their portfolio - Quiver Quantitative

Oct 24, 2025
pulisher
Oct 24, 2025

Boston Scientific Corporation (NYSE:BSX) Q3 2025 Earnings Call Transcript - Insider Monkey

Oct 24, 2025
pulisher
Oct 24, 2025

Should Boston Scientific’s (BSX) Upbeat Q3 Results and Raised Guidance Prompt Investor Action? - Yahoo Finance

Oct 24, 2025
pulisher
Oct 23, 2025

Boston Scientific Corporation (BSX) Announces Board Member John E. Sununu's Decision Not to Seek Re-election - GuruFocus

Oct 23, 2025
pulisher
Oct 23, 2025

Boston Sci Farapulse, Watchman boost Q3 performance - BioWorld MedTech

Oct 23, 2025
pulisher
Oct 23, 2025

Boston Scientific director John E. Sununu to step down after 2026 annual meeting - Investing.com

Oct 23, 2025
pulisher
Oct 23, 2025

Boston Scientific Announces Board Member Departure - TradingView

Oct 23, 2025
pulisher
Oct 23, 2025

Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst - Benzinga

Oct 23, 2025
pulisher
Oct 23, 2025

BSX Q3 Deep Dive: WATCHMAN and Electrophysiology Drive Outperformance, Guidance Raised - The Globe and Mail

Oct 23, 2025
pulisher
Oct 23, 2025

BSX: Morgan Stanley Raises Price Target on Boston Scientific | B - GuruFocus

Oct 23, 2025
pulisher
Oct 23, 2025

BSX: Today's Analyst Ratings Maintain Boston Scientific's Buy Ra - GuruFocus

Oct 23, 2025
pulisher
Oct 23, 2025

Here's Why Boston Scientific (BSX) is a Strong Growth Stock - Yahoo Finance

Oct 23, 2025
pulisher
Oct 23, 2025

Wells Fargo Raises Price Target for Boston Scientific (BSX) to $125 | BSX Stock News - GuruFocus

Oct 23, 2025
pulisher
Oct 23, 2025

Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors - Yahoo Finance

Oct 23, 2025
pulisher
Oct 23, 2025

Boston Scientific stock price target raised by UBS to $140 on strong growth - Investing.com

Oct 23, 2025
pulisher
Oct 23, 2025

Boston Scientific stock price target raised to $130 from $128 at Leerink - Investing.com

Oct 23, 2025
pulisher
Oct 23, 2025

GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to - GlobeNewswire

Oct 23, 2025
pulisher
Oct 23, 2025

GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex - Yahoo Finance

Oct 23, 2025
pulisher
Oct 23, 2025

Boston Scientific Corp (BSX) Q3 2025 Earnings Call Highlights: Strong Sales Growth and ... By GuruFocus - Investing.com Canada

Oct 23, 2025
pulisher
Oct 23, 2025

Boston Scientific (BSX): Earnings Jump 37%, Profit Margins Beat Bull Case Expectations - Yahoo

Oct 23, 2025
pulisher
Oct 22, 2025

Boston Scientific: Q3 Earnings Snapshot - New Haven Register

Oct 22, 2025

Boston Scientific Corp Stock (BSX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices SYK
$378.86
price down icon 1.42%
medical_devices MDT
$93.90
price down icon 0.23%
medical_devices ABT
$127.25
price up icon 0.03%
medical_devices EW
$82.06
price up icon 1.56%
$78.98
price up icon 0.77%
Cap:     |  Volume (24h):